 BOTHELL, Wash., Sept. 1, 2021 PRNewswire -- BioLife Solutions, Inc. Nasdaq: BLFS BioLife or the Company, a leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today announced that it has closed its acquisition of Sexton Biotechnologies. 